UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Carnival Corporation Ltd
CCL
$38.1B
| $166M | 0.03% |
6,677,249
+4,239,919
| +174% | +$99.2M |
|
602
PUT
IBM
IBM
$211B
| $166M | 0.03% |
756,400
-115,400
| -13% | -$25.7M |
|
603
Vanguard Energy ETF
VDE
$10.1B
| $166M | 0.03% |
1,365,237
+37,436
| +3% | +$4.77M |
|
604
Skyworks Solutions
SWKS
$9.37B
| $165M | 0.03% |
1,866,174
+905,038
| +94% | +$82.2M |
|
605
Novartis
NVS
$297B
| $165M | 0.03% |
1,697,511
+327,690
| +24% | +$34.9M |
|
606
iShares MSCI Brazil ETF
EWZ
$9.28B
| $165M | 0.03% |
7,336,230
+4,520,537
| +161% | +$121M |
|
607
Expeditors International
EXPD
$22B
| $165M | 0.03% |
1,488,926
+906,067
| +155% | +$108M |
|
608
TKO Group
TKO
$13.6B
| $165M | 0.03% |
1,160,096
+715,207
| +161% | +$93.4M |
|
609
CALL
Jabil
JBL
$33B
| $165M | 0.03% |
1,143,800
+25,800
| +2% | +$3.38M |
|
610
CALL
Goldman Sachs
GS
$300B
| $164M | 0.03% |
286,806
+206,198
| +256% | +$115M |
|
611
JD.com
JD
$44.6B
| $164M | 0.03% |
4,736,606
+1,454,113
| +44% | +$56.3M |
|
612
CALL
Visa
V
$684B
| $164M | 0.03% |
519,604
-42,716
| -8% | -$12.8M |
|
613
iShares TIPS Bond ETF
TIP
$14.5B
| $164M | 0.03% |
1,539,076
-291,099
| -16% | -$31.5M |
|
614
CALL
Johnson & Johnson
JNJ
$618B
| $164M | 0.03% |
1,133,495
+224,000
| +25% | +$34.7M |
|
615
Stanley Black & Decker
SWK
$14.3B
| $163M | 0.03% |
2,033,702
+1,372,159
| +207% | +$127M |
|
616
McCormick & Company Non-Voting
MKC
$13.7B
| $163M | 0.03% |
2,138,669
+1,211,431
| +131% | +$95.2M |
|
617
CALL
PayPal
PYPL
$48.9B
| $162M | 0.03% |
1,898,192
+1,539,722
| +430% | +$129M |
|
618
Halliburton
HAL
$26.9B
| $162M | 0.03% |
5,955,230
+2,765,388
| +87% | +$80.8M |
|
619
Vanguard Russell 2000 ETF
VTWO
$17.3B
| $162M | 0.03% |
1,811,779
+209,030
| +13% | +$19.3M |
|
620
Carlyle Group
CG
$16.6B
| $162M | 0.03% |
3,201,433
+2,548,132
| +390% | +$129M |
|
621
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.07B
| $162M | 0.03% |
3,203,295
+159,333
| +5% | +$8.05M |
|
622
Vanguard Russell 1000 ETF
VONE
$8.27B
| $161M | 0.03% |
604,823
+7,569
| +1% | +$2.03M |
|
623
iShares MBS ETF
MBB
$38.9B
| $161M | 0.03% |
1,759,343
+45,070
| +3% | +$4.2M |
|
624
PUT
Uber
UBER
$143B
| $161M | 0.03% |
2,670,300
+817,400
| +44% | +$58.4M |
|
625
PUT
Pinduoduo
PDD
$126B
| $161M | 0.03% |
1,658,250
+130,170
| +9% | +$15.1M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.